• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Luke Kanyang’areng becomes first Kenyan to receive Human Rights and Nursing Award

Home > News

Luke Kanyang’areng becomes first Kenyan to receive Human Rights and Nursing Award

Turku, Finland — 28 Aug 2025

The Drugs for Neglected Diseases initiative (DNDi) congratulates Luke Kanyang’areng, a nurse and patient advocate from West Pokot, for becoming the first Kenyan to receive the Human Rights and Nursing Award for his role in advocating for the human rights of neglected patients.

The annual Human Rights and Nursing Awards are presented to exemplary nurses for their outstanding commitment to the promotion of human rights and the nursing philosophy of humanity. The aim of the award is to highlight and celebrate nurses whose work fosters international recognition and respect for the human rights and dignity of people everywhere.

The 2025 Human Rights and Nursing Awards were presented at the 25th International Nursing Ethics conference in association with the Nursing Ethics journal on 28 August at the University of Turku, Finland.

Luke Kanyang’areng and Marianne Olander were the 2025 recipients of the annual Human Rights and Nursing Awards.

‘This recognition empowers me to intensify my efforts to raise awareness and improve healthcare access for neglected diseases,’ Luke said in his acceptance speech.

Luke’s journey is unique. As a teenager, he nearly lost his life to visceral leishmaniasis (also called kala-azar), a neglected tropical disease that is the second deadliest killer after malaria. The gruelling 30-day treatment and painful recovery left a lasting impact on him, and he went on to become a nurse at the very hospital that saved his life.

‘I wanted to understand how to care for vulnerable patients, and to dedicate my life to ensure others do not suffer as I did. Each patient I’ve cared for has reminded me of my own journey,’ continued Luke.

Today, Luke is not only a dedicated nurse but also a lifeline for countless individuals in his community. For over 20 years, he has worked tirelessly in West Pokot County, providing care to patients with leishmaniasis and other diseases. As the former nurse-in-charge at Kacheliba Sub-County Hospital, the same facility where he was treated as a child, he has led clinical care, trained colleagues, and treated hundreds of patients with empathy and dedication.

He currently serves at Kanyarkwat Health Centre where he continues to advocate for patients and raise awareness in communities where myths and stigma often prevent timely treatment.

Luke aims to use the award to conduct community outreach in hard-to-reach areas on the weekends and offer health talks focused on prevention, early diagnosis, and treatment-seeking behavior related to kala-azar. Luke is also recruiting local ambassadors to assist in educating communities about kala-azar screening, diagnosis, and treatment.

Watch our short-film on voices of leishmaniasis featuring Luke

Photo credit: Rowan Pybus-DNDi

Visceral leishmaniasis Africa

Read, watch, share

Loading...
Statements
13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

Press releases
10 Nov 2025

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

Press releases
4 Nov 2025

European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

Woman in rural village
Publications
29 Oct 2025

Chagas Platform Newsletter N°15

Jessica Robbins
Stories
24 Oct 2025

Jessica Robbins: A long and difficult journey with cutaneous leishmaniasis

Videos
24 Oct 2025

Road to Elimination of Kala-azar in South Asia

Videos
22 Oct 2025

The Boy Who Beat the Sandfly

News
14 Oct 2025

Twenty years of the Regional Kala-azar Elimination Initiative in South Asia

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license